Jacobs Levy Equity Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Jacobs Levy Equity Management's TNGX Position: Q3 2025 in Review
Jacobs Levy Equity Management sold out of Tango Therapeutics (TNGX) in Q3 2025, closing a stake of 218,779 shares — an estimated $1.12M sold.
Jacobs Levy Equity Management first reported a position in TNGX in Q3 2022 and held it in 10 quarters. The position peaked at $2.51M in Q4 2022. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.
- Jacobs Levy Equity Management reported no remaining Tango Therapeutics position as of Q3 2025 after selling out during the quarter.
- Jacobs Levy Equity Management sold 218,779 Tango Therapeutics shares in Q3 2025, an estimated $1.12M.
- Jacobs Levy Equity Management first reported a position in Tango Therapeutics in Q3 2022 and held it in 10 quarters.
- Jacobs Levy Equity Management's Tango Therapeutics position peaked at $2.51M in Q4 2022.
- 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.